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ABSTRACT 
 
Telomerase, a potential marker for tumorigenesis, has been found to be activated in more than 
85-90% of human cancer. Curcumin is the major biologically active, yellow phytochemical 
compound of Curcuma longa (Zingiberaceae). The present study is aimed to investigate the 
capacity of curcumin on the regulation of telomerase activity and induction of apoptosis in 
P388D1 mouse lymphoma cells. Here, we demonstrate that curcumin at a concentration of 3.5 
µM and an incubation period of 48h induces apoptosis and inhibits telomerase activity in the 
P388D1 cells. Curcumin induced apoptosis and telomerase activity in P388D1 lymphoma 
cells was confirmed by enumeration of apoptotic cells, % DNA fragmentation and RT-PCR. 
The culture supernatant of lymphoma cells treated with curcumin showed a higher level of 
nitric oxide content. RT-PCR analysis revealed over expression of TNF-α and IL-1β and inhi-
bition of the antiapoptotic Bcl-2 and human catalytic subunit hTERT in the curcumin treated 
lymphoma cells as compared to untreated cells. Taken together the result shows that curcumin 
could significantly inhibit tumor proliferation and induce apoptosis in lymphoma cells. Thus, 
curcumin should be further tested as a possible antineoplastic agent.  
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INTRODUCTION 
 
Curcumin (diferuloylmethane), a poly-
phenolic compound (molecular formula 
C21H20O6 ) isolated from the plant Curcuma 
longa, has been widely used as a spice and 
coloring agent (Araÿjo and Leon, 2001; 
Goel et al., 2008). Curcumin (Figure 1) acts 
as potent antioxidant, anti-inflammatory 
and antiproliferative therapeutic agent 
(Jagetia and Aggarwal, 2007; Alaikov et al., 
2007). Commercially, curcumin contains 
approximately 77 % diferuloylmethane, 
17 % demethoxycurcumin, and 6 % bisde-
methoxycurcumin (Goel et al., 2008).  
 
Figure 1: The structure of curcumin 
 
Recently, curcumin has gained special in-
terest due to its curative impact on numer-
ous ailments such as wound healing, diabe-
tes, Alzheimer disease, Parkinson disease, 
cardiovascular disease, pulmonary disease 
and arthritis (Goel et al., 2008). Curcumin 
can act as a potent immunomodulatory 
agent that can modulate the activation of 
T cells, B cells, macrophages, neutrophils, 
natural killer cells, and dendritic cells (Gau-
risankar and Das, 2008; Jagetia and Aggar-
wal, 2007). Several reports have docu-
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mented that curcumin can induce apoptosis 
in cancer cells from liver, colon, breast, 
stomach and duodenal tissue (Shi et al., 
2006).  
Reports suggest apoptosis involves 
changes in the expression of apoptotic 
agent’s like Bcl-2, TNF-α and IL-1B ap-
pears to be a critical determinant of a cells 
threshold for undergoing apoptosis (Anand 
et al., 2008). Curcumin has been shown to 
downregulate the expression of various pro-
inflammatory cytokines including TNF-α 
and interleukin-1, through inactivation of 
the transcription factor NF-κB (Jagetia and 
Aggarwal, 2007). Thus, TNF-α and IL-1β 
could be identified as the therapeutic targets 
in cancer therapy. Extensive research work 
suggest that curcumin acts as a potent scav-
enger of a variety of reactive oxygen spe-
cies (ROS) including superoxide anion 
(Khar et al., 2001), hydroxyl radical, singlet 
oxygen (Subramanian et al., 1994), and ni-
tric oxide radicals (Sreejayan and Rao, 
1997) that leads to apoptosis in several can-
cer cell lines (Woo et al., 2003; Anand et 
al., 2008). 
Telomere is a repeating (5’-TTAGGG-
3’), non-coding DNA sequence located at 
terminal ends of the chromosomes (Moyzis 
et al., 1988). Telomere is regulated by an 
enzyme namely telomerase, a ribonucleo-
protein, with the function of a DNA poly-
merase. The telomerase holoenzyme con-
sists of the catalytic subunit reverse tran-
scriptase protein hTERT (Nakamura et al., 
1997), the telomerase RNA template sub-
unit, hTR, that provides a template r-5’-
CUAACCCUAAC-3’ (Feng et al., 1995) 
and other associated proteins (Harrington et 
al., 1997). A strong correlation has been 
shown between TERT mRNA expression 
and telomerase activity in a variety of can-
cer cells such as breast, colon, gallbladder, 
lung, stomach and oesophagus (Jagetia and 
Aggarwal, 2007; Alaikov et al., 2007; Goel 
et al., 2008; Salvioli et al., 2007). Reports 
suggest that human telomerase subunit 
hTERT overwhelmingly activated in 80 % 
human cancer cells, which prevents te-
lomere shortening and activate apoptotic 
phenomena (Watanabe 2001; Mukherjee et 
al., 2007). Telomerase is thus proving to be 
a reliable marker for the proliferating ca-
pacity and tumor mass of cancer patients 
(Watanabe 2001; Gao and Chen, 2007). 
This makes telomerase a good target for 
cancer diagnosis. The present work was un-
dertaken to investigate the underlying 
mechanism involved in induction of apop-
tosis and chemoprevention by curcumin in 
P388D1 cells. 
 
MATERIALS AND METHODS 
Cell lines and treatment with curcumin 
P388D1 mouse lymphoma cells were 
obtained from the National Centre for Cell 
Science, Pune, India. Cells were cultured in 
DMEM culture medium, supplemented 
with 4 mM L-glutamine containing 10 % 
fetal bovine serum, penicillin (100 IU/ml) 
and streptomycin (100 mg/ml) at 37 0C with 
5 % CO2 in air. Before each experiment, 
cells were passaged three times. Curcumin 
was dissolved in dimethyl sulfoxide 
(DMSO) and diluted further in water. 
P388D1 cells were treated with curcumin at 
a final concentration of 3.5 µM for 48 h. 
Cells cultured in media containing an 
equivalent concentration of DMSO and 
without curcumin served as a control. 
 
Morphological evaluation of apoptotic 
cells 
Percentage of apoptotic cells were 
measured using standard protocol of Kerr et 
al. (1972), where apoptotic cells were 
stained with Wright’s staining. After cur-
cumin treatment, cells were removed from 
the culture plate using Trypsin/EGTA. A 
drop of cell suspension after air drying was 
fixed in methanol and stained with Wright’s 
solution, and then mounted in a permanent 
medium and analyzed. Apoptotic cells were 
identified on the basis of morphological 
features that included, contracted cell bod-
ies, condensed uniformly circumscribed and 
densely stained chromatin or membrane 
bound apoptotic bodies containing one or 
more nuclear fragments. 
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Agarose gel electrophoresis of DNA 
Extraction of DNA from P388D1 lym-
phoma was performed following the 
method given by Pringent et al. (1993) with 
some modifications. Cell suspension was 
washed in PBS and lysed in 0.5 ml of lysis 
buffer containing  mM Tris HCl, 75 mM 
NaCl 10 mM EDTA, 0.5 % SDS and 
0.15 mg/ml proteinase K and incubated for 
4 h at 50 0C. Lysates were spun down at 
10,000xg for 20 min at 4 0C. The super-
natant was collected carefully and a solu-
tion of 0.5 M NaCl and 50 % absolute etha-
nol was added to precipitate DNA. The pre-
cipitated DNA was resolubilized in 30 µl 
TE buffer (10 mM Tris HCl and 1 mM 
EDTA, pH 8.0) for 1h at 60 0C and then 
10 µl of loading dye (bromophenol blue 
0.025 %, xylene cyanol and 30 % glycerol 
in water) was added. 40 µl of the sample 
was loaded into the well of 1.5 % agarose 
gel and electrophoresed in the presence of 
0.5 µg/ml ethidium bromide. After the run, 
DNA was visualized and photographed on a 
UV transilluminator. 
 
DNA fragmentation assay  
A quantitative determination of DNA 
fragmentation was carried out according to 
the method of Sellins and Cohen (1987), 
with minor modifications. Cells (1 x 106 
cells/ml) were lysed in 0.5 ml Tris-EDTA 
buffer, pH 7.4, containing 0.2 % (v/v) Tri-
ton X-100 and the fragmented DNA was 
separated from intact chromatin in a micro-
fuge tube (labelled as A) by centrifugation 
at 13,000 g at 4 0C for 10 min. Supernatant 
containing fragmented DNA was trans-
ferred to second microfuge tube (labelled as 
T). 25 % TCA (0.5 ml) was added to each 
T and B tube and vortexed vigorously. 
DNA was precipitated overnight at 4 0C and 
pelleted by centrifugation at 13,000 g at 
4 0C for 10 min. Supernatants were dis-
carded and 80 µl of 5 % TCA was added to 
each pellet. DNA was hydrolyzed by heat-
ing at 90 0C for 15 min. At this stage, a 
blank was included containing 80 µl of 5 % 
TCA. A 160 µl aliquot of freshly prepared 
DPA reagent [150 mg diphenylamine in 
10 ml glacial acetic acid, 150 µl concen-
trated H2SO4 and 50 µl of acetaldehyde so-
lution] were added and the samples were 
allowed to stand overnight at room tem-
perature to develop colour. 100 µl of the 
resulting coloured solution was transferred 
to a 96-well, flat-bottomed ELISA plate and 
optical density was measured at 600 nm in a 
microtiter plate reader. The percentage of 
DNA fragmentation was calculated as: 
% DNA fragmentation= [T/ (T+B)] x 100. 
Samples were carried out in duplicate. Blue 
colour was developed in both treated and 
untreated samples. 
 
Assay for NO production 
The nitrite concentration in medium 
was measured following according to 
Srivastava et al. (2004). Briefly, 100 µl of 
cell-free culture supernatants were collected 
from each well of the 96-well microplates. 
An equal volume of Griess reagent (one 
part 1 % sulfanilamide in 2.5 % H3PO4 plus 
one part 0.1 % naphthylethylenediamine 
dihydrochloride in distilled water) was 
added and the mixture incubated for 10 min 
at room temperature. The absorbance at 
540 nm was measured with an automatic 
microplate reader. Nitrite concentrations 
were calculated using sodium nitrite as a 
standard. Data were expressed as µM ni-
trite/1.5 x105 cells originally plated. In all 
experiments nitrite contents in wells con-
taining medium without cells were also 
measured and subtracted from the values in 
the presence of cells. Samples were carried 
out in triplicate. Pink colour was developed 
in both treated and untreated samples. The 
amount produced was expressed as 
1x10-7 mM. 
Isolation of RNA 
Total cellular RNA was extracted from 
P388D1 cells using GeNei Total RNA ex-
traction Kit according to the manufacturer's 
instructions. Samples were resuspended in 
RNase-free water. RNA was quantified 
from the absorbance recorded at an optical 
density of 260 nm (Jenway, Essex, UK).   
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RT-PCR analysis of hTERT, hTR, Bcl-2, 
IL-1β and TNF-α 
The resulting RNA was subjected to 
single step RT-PCR using the GeNei one 
step RT-PCR Kit; according to the manu-
facturer's instructions. Briefly, 3 µg RNase-
free RNA template was subjected to RT-
PCR amplification in a final volume of 
25 µl. The template RNA used for amplifi-
cation was denatured at 65 0C for 5 min, 
followed by heating at 55 0C for 45 min for 
initial cDNA preparation in the presence of 
reverse transcriptase. The primer sets used 
for each gene of interest were as follows:  
Bcl-2: 5`-primers: 5`-
GAACACCAGAATCAAGTGTTCG-3` and 5`-
CAGGTGGACCACAGGTGGC-3`, size of ampli-
cons: 455 bp; TNF-α, 5`-primer: 5`-
ATGAGCACTGAAAGCATGATCCGG-3` and 
5`GCAATGATCCCAAAGTAGACCTGC-3`, ‘size 
of amplicons: 695 bp; IL-1β, 5`-primer: 5`-
ATGGCAGAAGTACCTAAGCTCGC-3` and 5`-
CACAAATTGCATGGTGAAGTCAG-3`, size of 
amplicon: 802 bp; β-Actin 5`- primer: 5`-
GGGTCAGAAGGATTCCTATG-3` and 5`-
CTAGAAGCATTTGCGGTGGAC-3`, size of am-
plicons: 1000 bp; hTERT, 5`-primer: 5`-
CGGAAGAGTGTCTGGAGCAA-3` and 3`- 
primer: 5`-GGATGAAGCGGAGTCTGGA-3`, size 
of amplicons: 145 bp; for hTR, 5`- primers 5`-
GGGTTGCGGAGGGTGGGCCT-3` and 3`- prim-
ers 5`-ACGGGCCAGCAGCTGACAT-3`, size of 
the amplicon 185 bp.  
The reaction master mix was prepared ac-
cording to the manufacturer’s protocol. The 
primer (Met. Int. AG, Deutschland, Ger-
many) concentration was 20 pmol for each 
set. Thermal programme was kept similar 
for all amplifications. The gene amplifica-
tions were performed with an initial incuba-
tion step at 94 °C for 3 min, followed by 
31 cycles at 94 °C for 60 seconds, 60 0C for 
1 min (Bcl-2: 58 0C for 1 min and hTERT: 
57 0C for 1 min) and 72 °C for 1.5 min with 
a final extension at 72 °C for 10 min. PCR 
products were separated by electrophoresis 
on a 2 % agarose gel containing ethidium 
bromide and DNA bands were detected in 
gel documentation unit (Bio-Rad Laborato-
ries, Hercules, CA, USA). The intensity of 
the bands corresponding to Bcl-2, TNF-α 
and IL-1B and β-actin were calculated using 
Quantiscan software. Due care was taken to 
prevent PCR carry over contamination, in-
cluding physical separation of the reaction 
area from the analysis area. Each RT-PCR 
was repeated twice and representative re-
sults are shown. Housekeeping genes β-
actin was used as internal control for equal 
loading. 
 
Statistical analysis 
All statistics were carried out using 
SPSS software. Values were expressed as 
mean ± SD. Group means are compared 
using the unpaired student's t-test. A prob-
ability value of 0.05 or less was considered 
significant. 
 
RESULTS 
 
Curcumin induced apoptosis of P388D1 
cells 
Cells treated with curcumin and subse-
quently visualised with Wright’s stain and 
examined under phase contrast microscope 
showed characteristic apoptotic features, 
such as chromatin condensation and nuclear 
fragmentation (Figure 2).  
 
 
Figure 2: Lymphoma cell undergoes apoptosis 
after treatment with 3.5 µM of curcumin for 
48 h, shows chromatin condensation, nuclear 
fragmentation, presence of apoptotic bodies 
and surface blabbing in an apoptotic cell.  
Other morphological features of apop-
tosis such as cell shrinkage and presence of 
apoptotic bodies were also evident. One 
hundred cells were scored at randomly and 
classified into apoptotic and non apoptotic 
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cells based on above characteristics. Per-
centage of apoptotic cells was increased by 
nearly 2 fold, as shown in Figure 3. 
Figure 3: Percent of apoptotic P388D1 cells 
observed under phase contrast microscope af-
ter treatment with 3.5 µM of curcumin for 48 h. 
Values represented mean ± S.D. (n=100) 
% DNA fragmentation assay  
To examine further the apoptotic char-
acteristics in curcumin-treated lymphoma 
cells, the % DNA fragmentation was de-
termined. Induction of apoptosis was evi-
dent (Figure 4), whereby the % DNA frag-
mentation was increased by more than 2-
fold in curcumin-treated cells compared to 
control cells.  
 
Figure 4: Percent of DNA fragmented P388D1 
cells after treatment with 3.5 µM of curcumin for 
48 h. 
 
DNA ladder profile 
To further examine the effect of curcu-
min on agarose gel electrophoresis on tu-
mor cells at 3.5 µM concentration for 48 h. 
Fragmented DNA ladders were observed in 
curcumin treated tumor P388d1 cells as rep-
resented in Figure 5. No significant frag-
mentation were observed in the untreated 
tumor cells (reference control).  
 
 
 
 
NO production analysis 
Curcumin treated and untreated culture 
supernatants of tumor cells, incubated in 
DMEM medium were analyzed for NO 
content. Culture supernatant of curcumin 
treated tumor cells showed higher level of 
NO content compared to untreated tumor 
cells. The NO content is shown in Figure 6, 
which demonstrates stimulation of NO pro-
duction in the curcumin treated lymphoma 
cells as compared to untreated cells.  
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Figure 5: Agarose 
gel electrophoresis 
profile of P388D1 
cells at 3.5 µM 
curcumin for 48 h. 
C indicate un-
treated and T for 
treated cells. 
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Figure 6: Nitric oxide produced by P388D1 
cells after treatment with 3.5 µM of curcumin for 
48 h. 
RT-PCR expression analysis of Bcl-2, IL-
1β and TNF-α 
To explore the possible mechanism by 
which curcumin induced apoptosis in 
P388D1 cells, the expression of both pro- 
and anti-apoptotic mRNA was analyzed by 
RT PCR analysis. Changes in the mRNA 
expression levels of Bcl-2, TNF-α and IL-
1B in P388D1 cells were measured, to ex-
amine their possible contribution to the 
mechanism of curcumin-induced apoptosis. 
RT-PCR analysis revealed that mRNA lev-
els of TNF-α and IL-1B (Figures 7 and 8) 
increased with a concomitant decrease in 
Bcl-2 mRNA (Figure 10). No significant 
changes were observed in the levels of β-
actin mRNA (reference control) (Figure 9). 
The expression level of Bcl-2 was de-
creased to 60 % of control levels at 3.5 µM 
of curcumin. By contrast, TNF-α and IL-1B 
levels were increased to 2 to 3 fold higher 
than control levels, at the same concentra-
tion of curcumin.  
 
 
 
Figures 7-10: RT–PCR analysis of TNF-α, IL-
1β, β-actin and Bcl-2 gene expression after 
treatment with 3.5 µM curcumin for 48 h, re-
spectively. Where lane: C represents P388D1 
cells without curcumin treatment and T repre-
sents with Curcumin treatment.  
 
 
RT PCR expression analysis of hTERT 
and hTR 
To assess the effects of curcumin on te-
lomerase activity, P388D1 cells were 
treated with 3.5 µM of curcumin for 48 h. 
Telomerase activity was analyzed by RT-
PCR profile of human telomerase catalytic 
subunit (hTERT) and RNA subunit of the 
human telomerase complex (hTR). Results 
are represented in Figures 11-13. Compared 
to untreated cells, the telomerase activity of 
P388D1 cells was significantly suppressed. 
Percentage inhibition of telomerase was 
calculated from band intensity. Intensity 
obtained from untreated cells was consid-
ered to have 100 % telomerase activity and 
accordingly intensities were calculated for 
the treated cells. Results revealed that the 
telomerase activity was inhibited to the ex-
tent of 25 % and 40 % after 48 h treatment 
with 3.5 µM curcumin, respectively. Ex-
pression levels were calculated from the 
intensities obtained in two to three inde-
pendent experiments.  
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Figures 11-13: RT–PCR analysis of hTERT, 
hTR and β-actin expression after treatment with 
3.5 µM curcumin for 48 h, respectively, where 
lane C represents P388D1 cells without curcu-
min treatment and T represents with Curcumin 
treatment.  
 
DISCUSSION 
 
Over the last decade, a significant re-
search interest has been generated around 
curcumin, the major constitutes of turmeric, 
because of its anti-inflammatory and anti-
neoplastic properties (D'Incalci et al., 
2005). However, hardly any study has been 
reported to date regarding effect of low 
dose of curcumin on induction of apoptosis 
via inhibited of telomerase activity and ac-
cumulated reactive oxygen species. In the 
present study, we focused on the effect of 
curcumin on telomerase activity to clarify 
the anti-proliferating effect of curcumin in 
P388D1 cells derived from mouse lym-
phoma/leukemia cells. Recent studies have 
indicated that inhibition of tumor cell 
growth is associated with the promotion of 
apoptosis and decrease in telomerase ex-
pression (Cui et al., 2006; Chakraborty et 
al., 2006) in a dose dependent manner 
(Mukherjee et al., 2007). Moreover, dose 
dependent cytotoxic effect of curcumin in 
induction of apoptosis in various cells has 
been well documented (Alaikov et al., 
2007). Curcumin mediated cell death was 
accompanied by characteristic morphologi-
cal changes like nuclear condensation and 
formation of apoptotic bodies, when exam-
ined under phase contrast microscope.  
The present findings illustrate that cur-
cumin induces the release of cytochrome c 
to translocate from mitochondria to cytosol 
at 3.5 µM concentration. Moreover, cyto-
chrome c is involved in the activation of 
caspases and thus initiates the apoptotic 
pathway (Khar et al., 2001). It has been 
suggested that low dose of curcumin treat-
ment leads to increased ROS generation in 
comparison to higher doses (Chan et al., 
2006). Furthermore, the release of cyto-
chrome c leads to inhibition of the mito-
chondrial respiratory chain, that could be 
assumed to the overproduction of ROS 
(Schulze-Osthoff et al., 1992). Studies 
demonstrated depletion of endogenous anti-
oxidant level or increase of ROS led induc-
tion of programmed cell death in various 
tumor cells (Buttke and Sandstrom, 1994). 
Therefore, curcumin induced generation of 
antioxidant associated with apoptosis at 
3.5 µM in P388D1 lymphoma/ leukemia 
cells could not be ignored.  
In vitro investigations have demon-
strated that Bcl-2 acts as a malignant factor 
causing various types of carcinoma, in-
cludes lung cancer and breast cancer (Ichi-
kawa et al., 2004). On the other hand TNF-
α and IL-1β are the key mediator of apop-
totic pathway, tumor proliferation and dif-
ferentiation (Mandal and Kumar, 1997). 
Studies suggest IL-1β acts synergistically 
with TNF-α, activates proinflammatory re-
sponses in a wide range of tumor cells 
(Goel et al., 2008; Cho et al., 2007). Studies 
demonstrated the expression of the catalytic 
subunit TERT correlates with telomerase 
activity during cellular differentiation and 
neoplastic transformation. Moreover, cur-
cumin mediated downregulation of telom-
erase activity is due to the inhibition of 
translocation of telomerase reverse tran-
scriptase (TERT) from cytosol to nucleus 
(Chakraborty et al., 2006). The present 
finding illustrates that suppression of tumor 
proliferation even in low doses of curcumin 
is due to the inhibitory effect of the curcu-
min by inhibition of various cytokines leads 
to apoptosis and involved in tumor prolif-
eration or inhibiting RNA transcription 
rather than direct inhibition of the telom-
erase activity. Therefore, telomerase inhibi-
tion by curcumin can be interpreted as an 
important event that leads to apoptosis. 
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Thus, inhibition of hTERT could be a pos-
sible potential therapeutic agent to induce 
cell death in tumor cells. 
 
CONCLUSION 
 
In conclusion, our work reveals that 
curcumin could significantly inhibit telom-
erase activity and induce apoptosis in 
P388D1 cells. Although, the modulation of 
telomerase expression by curcumin in can-
cer cells is poorly understood. Therefore, 
curcumin may inhibit cancer cell growth 
and induce apoptosis via reducing telom-
erase expression.The present investigation 
suggests that even low dose of curcumin is 
sufficient to develop curcumin as possible 
potential universal antineoplastic agent.  
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